Your browser doesn't support javascript.
loading
EANM guideline on quality risk management for radiopharmaceuticals.
Gillings, Nic; Hjelstuen, Olaug; Behe, Martin; Decristoforo, Clemens; Elsinga, Philip H; Ferrari, Valentina; Kiss, Oliver C; Kolenc, Petra; Koziorowski, Jacek; Laverman, Peter; Mindt, Thomas L; Ocak, Meltem; Patt, Marianne; Todde, Sergio; Walte, Almut.
Afiliação
  • Gillings N; Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Hjelstuen O; GE Healthcare, Pharmaceutical Diagnostics, Oslo, Norway.
  • Behe M; Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen, Switzerland.
  • Decristoforo C; Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
  • Elsinga PH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.
  • Ferrari V; MSD Animal Health, Milton Keynes, UK.
  • Kiss OC; Department of Radiopharmaceuticals Production, Institute for Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany. o.kiss@hzdr.de.
  • Kolenc P; Department of Nuclear Medicine and Faculty of Pharmacy, University Medical Centre Ljubljana and University of Ljubljana, Ljubljana, Slovenia.
  • Koziorowski J; Independent Consultant, Linköping, Sweden.
  • Laverman P; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands.
  • Mindt TL; Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
  • Ocak M; Department of Pharmaceutical Technology, Istanbul University, Istanbul, Turkey.
  • Patt M; Department for Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
  • Todde S; Tecnomed Foundation, University of Milano-Bicocca, Monza, Italy.
  • Walte A; Department of Nuclear Medicine, Hannover Medical School, Hanover, Germany.
Eur J Nucl Med Mol Imaging ; 49(10): 3353-3364, 2022 08.
Article em En | MEDLINE | ID: mdl-35385986

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Radiofarmacêuticos / Medicina Nuclear Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Radiofarmacêuticos / Medicina Nuclear Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Ano de publicação: 2022 Tipo de documento: Article